Evidence map›Paper›PMID 36890892›Full record

ArticleFrontiers in plant science2023

Virginie Korangi Alleluya, Anthony Argüelles Arias, Bianca Ribeiro, Barbara De Coninck, Catherine Helmus, Pierre Delaplace, Marc Ongena

Open access · goldAbstract read
In one paragraph

Article in Frontiers in plant science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
7.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. An EndophyticJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Microorganisms · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. From genome to field:Current research in microbial sciences · 2025
    Article
  9. Frontiers in plant science · 2024
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Virginie Korangi AlleluyaMicrobial Processes and Interactions Laboratory, Terra Teaching and Research Center, Gembloux Agro-Bio Tech, Liège University, Gembloux, Belgium.
Anthony Argüelles AriasMicrobial Processes and Interactions Laboratory, Terra Teaching and Research Center, Gembloux Agro-Bio Tech, Liège University, Gembloux, Belgium.
Bianca RibeiroDivision of Plant Biotechnics, Department of Biosystems, Faculty of Bioscience Engineering, Katholieke Universiteit (KU) Leuven, Leuven, Belgium.
Barbara De ConinckDivision of Plant Biotechnics, Department of Biosystems, Faculty of Bioscience Engineering, Katholieke Universiteit (KU) Leuven, Leuven, Belgium.
Catherine HelmusMicrobial Processes and Interactions Laboratory, Terra Teaching and Research Center, Gembloux Agro-Bio Tech, Liège University, Gembloux, Belgium.
Pierre DelaplacePlant biology Unit, Gembloux Agro-Bio Tech, Liège University, Gembloux, Belgium.
Marc OngenaMicrobial Processes and Interactions Laboratory, Terra Teaching and Research Center, Gembloux Agro-Bio Tech, Liège University, Gembloux, Belgium.
Gembloux Agro-Bio Tech · BEKU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Peanut ( Results and discussion: Upon growth under the nutritional conditions dictated by peanut root exudation, the bacterium efficiently produces the three types of lipopeptides surfactin, iturin and fengycin known for their antagonistic activities against a wide range of fungal phytopathogens. By testing a range of GA1 mutants specifically repressed in the production of those metabolites, we point out an important role for iturin and another unidentified compound in the antagonistic activity against the pathogen. Biocontrol experiments performed in greenhouse further revealed the efficacy of

Indexed as

Arachis hypogaea L.B. velezensisdisease protectionlipopeptidessecondary metabolitessystemic resistance

Identifiers

PMID36890892
PMCPMC9986434
OpenAlexW4321376733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.